.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 5,550,269

« Back to Dashboard

Claims for Patent: 5,550,269

Title: Method for redistribution of trichlorosilane
Abstract:A method for the redistribution of trichlorosilane in the presence of N,N,N',N'-tetraethylethylenediamine (TEEDA) to form a complex comprising dichlorosilane and TEEDA. The dichlorosilane can be disassociated from the TEEDA by a means such as heating and then used in standard processes requiring dichlorosilane. Alternatively, the complex comprising the dichlorosilane and TEEDA can be used as a reactant for hydrosilation of .alpha.,.beta.-unsaturated olefinic nitriles or reacted with Grignard type reagents to make organosilanes.
Inventor(s): Boudjouk; Philip (Fargo, ND), Kloos; Steven D. (Chanhassen, MN)
Assignee: North Dakota State University Research Foundation (Fargo, ND)
Application Number:08/560,456
Patent Claims: 1. A method for redistribution of trichlorosilane, the method comprising:

(A) contacting trichlorosilane with N,N,N'N'-tetraethylethylenediamine forming a complex comprising dichlorosilane and N,N,N',N'-tetraethylethylenediamine and

(B) recovering the complex comprising dichlorosilane and N,N,N',N'-tetraethylethylenediamine.

2. A method according to claim 1, where the method is conducted in liquid phase.

3. A method according to claim 1, where the mole ratio of trichlorosilane to N,N,N',N'-tetraethylethylenediamine added to the method is within a range of about 0.1:1 to 10:1.

4. A method according to claim 1, where the mole ratio of trichlorosilane to N,N,N',N'-tetraethylethylenediamine added to the method is within a range of about 2:1 to 5:1.

5. A method according to claim 2, where the trichlorosilane is contacted with the N,N,N',N'-tetraethylethylenediamine in the presence of an organic solvent in which the resulting complex is soluble.

6. A method according to claim 5, were the organic solvent is selected from a group consisting of dichloromethane and 1,2-dichloroethane.

7. A method according to claim 5, where the organic solvent is dichloromethane.

8. A method according to claim 5, where the volume of organic solvent added to the method is within a range of about 0.3 volume to an equal volume of the combined total volume of the trichlorosilane and N,N,N',N'-tetraethylethylenediamine.

9. A method according to claim 2, where recovery of the complex comprising dichlorosilane and N,N,N',N'-tetraethylethylenediamine is effected by precipitation with an organic solvent which effects precipitation of the complex.

10. A method according to claim 9, where the organic solvent is selected from a group consisting of hexane, pentane, and tetrahydrofuran.

11. A method according to claim 9, where the organic solvent is pentane.

12. A method according to claim 2, where the trichlorosilane is contacted with the N,N,N',N'-tetraethylethylenediamine at a mole ratio in a range of about 2:1 to 5:1 in the presence of an organic solvent in which the resulting complex is soluble and recovery of the complex is effected by the addition of an organic solvent which effects precipitation of the complex.

13. A method according to claim 1, where the trichlorosilane is contacted with the N,N,N',N'-tetraethylethylenediamine at a temperature within a range of about 15.degree. C to 30.degree. C.

14. A composition comprising dichlorosilane and N,N,N',N'-tetraethylethylenediamine prepared by the process of claim 1.

15. A composition comprising a complex of dichlorosilane and N,N,N',N'-tetraethylethylenediamine.

16. A method of forming an organosilane, the method comprising contacting a complex comprising dichlorosilane and N,N,N',N'-tetraethylethylenediamine with a reagent described by formula RMgCl, where R is an alkyl or aryl radical.

17. A method of forming a cyanoalkylsilane, the method comprising contacting a complex comprising dichlorosilane and N,N,N',N'-tetraethylethylenediamine with an .alpha.,.beta.-unsaturated olefinic nitrile described by formula YCH=C(Y) CN, where each Y is independently selected from a group consisting of hydrogen and lower alkyl radicals comprising one to eight carbon atoms.

18. A method according to claim 17, where the unsaturated olefinic nitrile is selected from a group consisting of acrylonitrile, methacrylonitrile, crotononitrile, ethylacrylonitrile, 1-cyanobutene-1, and 2-cyanooctene-1.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc